Parkside Financial Bank & Trust’s Apellis Pharmaceuticals APLS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.79K	Buy	119 +86	+261%	+$1.85K	﹤0.01%	1838
2025 Q4	$829	Sell	33 -3	-8%	-$70	﹤0.01%	2404
2025 Q3	$815	Hold	36	–	–	﹤0.01%	2370
2025 Q2	$624	Buy	36 +31	+620%	+$574	﹤0.01%	2424
2025 Q1	$110	Sell	5 -24	-83%	-$663	﹤0.01%	2714
2024 Q4	$926	Sell	29 -1	-3%	-$30	﹤0.01%	1757
2024 Q3	$866	Sell	30 -14	-32%	-$518	﹤0.01%	1734
2024 Q2	$1.69K	Hold	44	–	–	﹤0.01%	1577
2024 Q1	$2.59K	Hold	44	–	–	﹤0.01%	1470
2023 Q4	$2.63K	Sell	44 -5	-10%	-$254	﹤0.01%	1449
2023 Q3	$1.86K	Buy	+49	New	+$2.15K	﹤0.01%	1679

Other funds holding APLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Parkside Financial Bank & Trust's APLS Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Apellis Pharmaceuticals (APLS) stake by 261% in Q1 2026, buying an estimated $1.85K and bringing the position to 119 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Parkside Financial Bank & Trust first reported a position in APLS in Q3 2023 and has held it in 11 quarters since. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

Parkside Financial Bank & Trust held 119 shares of Apellis Pharmaceuticals worth $4.79K as of Q1 2026.
Parkside Financial Bank & Trust bought 86 Apellis Pharmaceuticals shares in Q1 2026, an estimated $1.85K.
Apellis Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1838 holding.
Parkside Financial Bank & Trust first reported a position in Apellis Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.